Population pharmacokinetics of gentamicin in patients with cancer (original) (raw)

Clinical Pharmacokinetics of Gentamicin

Yousef Allanqawi

Medical Principles and Practice, 2009

View PDFchevron_right

Comparison of non-kinetic and kinetic approaches to individualization of gentamicin dosage

sayful islam

European Journal of Clinical Pharmacology, 1990

View PDFchevron_right

Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer

Daniele Ouellet

Cancer Chemotherapy and Pharmacology, 2000

View PDFchevron_right

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients

Miroslav Ravic

Anti-Cancer Drugs, 2002

View PDFchevron_right

Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer

Peter Steinherz

Cancer Chemotherapy and Pharmacology, 2011

View PDFchevron_right

Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate

Andrew McLachlan

British Journal of Clinical Pharmacology, 2008

View PDFchevron_right

THERAPEUTIC DRUG MONITORING OF GENTAMICIN: A PROSPECTIVE STUDY

Amit Sharma

View PDFchevron_right

Applied Clinical Pharmacokinetics

Brian Byrd

View PDFchevron_right

Population pharmacokinetics of total and unbound plasma cisplatin in adult patients

Brett McWhinney

British Journal of Clinical Pharmacology, 2004

View PDFchevron_right

Therapeutic drug monitoring of cancer chemotherapy

lamya alnaim

Journal of Oncology Pharmacy Practice, 2007

View PDFchevron_right

Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study

Michel Ducher

Fundamental & Clinical Pharmacology, 2010

View PDFchevron_right

Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics

Alain Astier

European Journal of Cancer, 2014

View PDFchevron_right

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents

Florent Puisset

British journal of cancer, 2012

View PDFchevron_right

PHARMACOKINETICS- CLINICAL PHARMACOLOGY

magendira mani vinayagam

View PDFchevron_right

Development of a new equation to estimate creatinine clearance in cancer patients

Michael Sawyer

Cancer chemotherapy and pharmacology, 2015

View PDFchevron_right

Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose

Pedro Póvoa

Clinical Microbiology and Infection, 2009

View PDFchevron_right

Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition

G. Kokwaro

Journal of Antimicrobial Chemotherapy, 2007

View PDFchevron_right

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients

Hiroshi Ishii

Clinical Pharmacokinetics, 2010

View PDFchevron_right

Development and validation of a method to determine the unbound paclitaxel fraction in human plasma

Samuel Carda-broch

Analytical Biochemistry, 2004

View PDFchevron_right

There is Only One Valid Definition of Clearance: Critical Examination of Clearance Concepts Reveals the Potential for Errors in Clinical Drug Dosing Decisions

George Makrygiorgos

The AAPS Journal

View PDFchevron_right

Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach

Rainer Trittler

Journal of the National Comprehensive Cancer Network, 2017

View PDFchevron_right

Pharmacokinetic variability of anticancer agents

Gonzalo Abuin

Nature Reviews Cancer, 2005

View PDFchevron_right

Population pharmacokinetics/pharmacodynamics relationships of an anticancer drug

Didier Concordet

Statistics in Medicine, 2003

View PDFchevron_right

Pharmacokinetic study to optimize the intravesical administration of gemcitabine

francesco carbone

BJU International, 2010

View PDFchevron_right

A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans

Athanassios Iliadis

Cancer Chemotherapy and Pharmacology, 1995

View PDFchevron_right

Clinical Pharmacokinetics

DAVID VASQUEZ

View PDFchevron_right

420 Population pharmacokinetic and pharmacodynamic modelling of E7820 in patients with solid tumor

Bipin Mistry

European Journal of Cancer Supplements, 2010

View PDFchevron_right

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients Treated with Platinum-Based Chemotherapy

Jose Luis Ceballos

Oncologist, 2007

View PDFchevron_right

Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides

Nick Holford

British Journal of Clinical Pharmacology, 2004

View PDFchevron_right

Population Analysis of the Pharmacokinetic Variability of High-Dose Metoclopramide in Cancer Patients1

Nick Bateman

Clinical Pharmacokinetics, 1988

View PDFchevron_right

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review

Charlot Vandevoorde

European Journal of Nuclear Medicine and Molecular Imaging, 2011

View PDFchevron_right

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

Barry Skikne

Cancer Chemotherapy and Pharmacology

View PDFchevron_right

Drug administration and blood sampling for pharmacokinetic studies in pediatric cancer patients

Carina Ritzmo

2009

View PDFchevron_right

Evaluation of Utility of Pharmacokinetic Studies in Phase I Trials of Two Oncology Drugs

Larry House

Clinical Cancer Research, 2013

View PDFchevron_right

Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using Preclinical In Vitro and in Vivo Data

Handan He

Integrative Approaches in Drug Discovery and Development, 2014

View PDFchevron_right